Share Price and Basic Stock Data
Last Updated: January 29, 2026, 6:00 pm
| PEG Ratio | 2.05 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CARE Ratings Ltd operates within the rating services industry, focusing on providing credit ratings, research, and risk management solutions. The company’s share price stood at ₹1,555, with a market capitalization of ₹4,672 Cr. Revenue trends indicate a robust growth trajectory, with sales recorded at ₹279 Cr for the fiscal year ending March 2023, rising to ₹332 Cr in March 2024, and further increasing to ₹402 Cr in March 2025. The trailing twelve months (TTM) revenue reached ₹436 Cr, showcasing a consistent upward movement. Quarterly sales figures also reflected this growth, with ₹96 Cr in September 2023 and projected growth to ₹136 Cr by September 2025. CARE Ratings has strategically positioned itself to capitalize on evolving market dynamics, which is evident from its operating profit margin (OPM) of 50%. This margin is significantly above the typical sector range, indicating effective cost management and operational efficiency.
Profitability and Efficiency Metrics
CARE Ratings demonstrated impressive profitability metrics, with a net profit of ₹155 Cr for the fiscal year ending March 2025, reflecting a solid increase from ₹85 Cr in March 2023. The company’s return on equity (ROE) stood at 18.0%, while the return on capital employed (ROCE) was recorded at 24.6%, both of which are favorable compared to industry averages. The company’s interest coverage ratio (ICR) was exceptionally high at 97.76x, indicating strong earnings relative to interest obligations. The operating profit margin varied throughout the quarters, with a notable peak of 50% in September 2025, demonstrating effective operational controls. The cash conversion cycle (CCC) was maintained at a favorable 29 days, suggesting efficient management of receivables and payables. Such metrics highlight CARE Ratings’ ability to generate profits while effectively managing operational costs.
Balance Sheet Strength and Financial Ratios
The financial strength of CARE Ratings is evident from its balance sheet, which reported total assets of ₹1,037 Cr as of September 2025. The company maintained minimal borrowings of ₹25 Cr, reflecting a conservative approach to leveraging, which enhances financial stability. With reserves amounting to ₹832 Cr, CARE Ratings has a strong equity base that supports its growth initiatives. The price-to-book value ratio stood at 4.09x, indicating a premium valuation compared to its book value of ₹269.37 per share. The current ratio of 7.08x and quick ratio of 7.08x indicate high liquidity, ensuring that the company can meet its short-term obligations comfortably. Furthermore, the net profit margin improved to 34.79% in March 2025, indicating effective cost management and profitability retention, thereby enhancing shareholder value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CARE Ratings reflects a diverse investor base, with foreign institutional investors (FIIs) holding 23.61% and domestic institutional investors (DIIs) at 31.60% as of September 2025. The public shareholding stood at 44.79%, with a total of 56,931 shareholders, indicating a healthy distribution of ownership. This diversity in the shareholder base can enhance corporate governance and attract investor confidence. The gradual increase in FIIs from 17.99% in December 2022 to 23.61% in September 2025 underscores growing international interest in the company. However, the decrease in public shareholding from 56.94% in December 2022 to 44.79% in September 2025 may raise concerns regarding retail investor participation. Overall, the robust institutional interest signals confidence in CARE Ratings’ growth trajectory and financial health.
Outlook, Risks, and Final Insight
Looking ahead, CARE Ratings is poised for continued growth driven by its strong market position and robust financial performance. However, risks such as regulatory changes in the rating industry and potential economic downturns could impact its operations. Additionally, competition from emerging players in the rating services space poses a threat to market share. The company’s high OPM and ROCE indicate efficient operations, but maintaining these metrics will be crucial amid evolving market conditions. In scenarios where economic stability is maintained, CARE Ratings could leverage its strong financial position to expand further. Conversely, any adverse regulatory developments could hinder growth prospects. Overall, the company’s solid fundamentals provide a strong foundation for navigating future challenges while capitalizing on opportunities in the rating services sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| ICRA Ltd | 5,999 Cr. | 6,222 | 7,135/5,015 | 31.7 | 1,127 | 0.96 % | 23.1 % | 16.8 % | 10.0 |
| CARE Ratings Ltd | 4,711 Cr. | 1,568 | 1,965/1,052 | 30.8 | 288 | 1.15 % | 24.6 % | 18.0 % | 10.0 |
| Industry Average | 5,355.00 Cr | 3,895.00 | 31.25 | 707.50 | 1.06% | 23.85% | 17.40% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 85 | 62 | 78 | 66 | 96 | 79 | 90 | 79 | 117 | 96 | 110 | 94 | 136 |
| Expenses | 43 | 48 | 50 | 49 | 55 | 55 | 61 | 57 | 62 | 66 | 62 | 66 | 68 |
| Operating Profit | 42 | 14 | 27 | 18 | 42 | 23 | 29 | 22 | 56 | 30 | 47 | 28 | 68 |
| OPM % | 50% | 22% | 35% | 27% | 43% | 30% | 32% | 28% | 47% | 32% | 43% | 30% | 50% |
| Other Income | 8 | 12 | 10 | 12 | 11 | 14 | 10 | 12 | 12 | 12 | 15 | 14 | 13 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 48 | 23 | 34 | 26 | 50 | 34 | 36 | 30 | 64 | 39 | 59 | 37 | 77 |
| Tax % | 27% | 28% | 41% | 31% | 29% | 30% | 32% | 30% | 27% | 27% | 26% | 29% | 26% |
| Net Profit | 35 | 16 | 20 | 18 | 36 | 24 | 25 | 21 | 47 | 28 | 43 | 26 | 57 |
| EPS in Rs | 11.57 | 5.38 | 6.60 | 5.99 | 11.81 | 7.88 | 8.07 | 6.94 | 15.41 | 9.29 | 14.24 | 8.61 | 18.89 |
Last Updated: January 2, 2026, 4:02 am
Below is a detailed analysis of the quarterly data for CARE Ratings Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 136.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Jun 2025) to 136.00 Cr., marking an increase of 42.00 Cr..
- For Expenses, as of Sep 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Jun 2025) to 68.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Jun 2025) to 68.00 Cr., marking an increase of 40.00 Cr..
- For OPM %, as of Sep 2025, the value is 50.00%. The value appears strong and on an upward trend. It has increased from 30.00% (Jun 2025) to 50.00%, marking an increase of 20.00%.
- For Other Income, as of Sep 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Jun 2025) to 13.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Jun 2025) to 77.00 Cr., marking an increase of 40.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Jun 2025) to 26.00%, marking a decrease of 3.00%.
- For Net Profit, as of Sep 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Jun 2025) to 57.00 Cr., marking an increase of 31.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 18.89. The value appears strong and on an upward trend. It has increased from 8.61 (Jun 2025) to 18.89, marking an increase of 10.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:31 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 261 | 279 | 287 | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 402 | 436 |
| Expenses | 88 | 101 | 105 | 105 | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 247 | 262 |
| Operating Profit | 148 | 160 | 174 | 182 | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 155 | 174 |
| OPM % | 63% | 61% | 62% | 63% | 63% | 55% | 33% | 39% | 32% | 36% | 34% | 39% | 40% |
| Other Income | 36 | 44 | 9 | 34 | 25 | 30 | 31 | 31 | 27 | 38 | 47 | 51 | 53 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 |
| Depreciation | 3 | 5 | 4 | 3 | 3 | 3 | 8 | 8 | 8 | 11 | 10 | 12 | 13 |
| Profit before tax | 181 | 197 | 178 | 212 | 233 | 202 | 104 | 119 | 99 | 126 | 147 | 192 | 212 |
| Tax % | 28% | 30% | 33% | 31% | 30% | 32% | 20% | 23% | 22% | 32% | 30% | 27% | |
| Net Profit | 130 | 138 | 120 | 148 | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 140 | 155 |
| EPS in Rs | 44.63 | 47.53 | 40.68 | 50.13 | 55.13 | 46.66 | 27.96 | 30.39 | 25.34 | 28.12 | 33.67 | 45.85 | 51.03 |
| Dividend Payout % | 63% | 166% | 69% | 56% | 100% | 64% | 70% | 56% | 67% | 89% | 53% | 39% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 6.15% | -13.04% | 23.33% | 9.46% | -14.81% | -39.86% | 9.64% | -15.38% | 10.39% | 21.18% | 35.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -19.20% | 36.38% | -13.87% | -24.27% | -25.04% | 49.49% | -25.02% | 25.77% | 10.79% | 14.75% |
CARE Ratings Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | 18% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 11% |
| 3 Years: | 22% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 30% |
| 3 Years: | 44% |
| 1 Year: | 55% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 1:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:05 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 | 30 | 30 |
| Reserves | 456 | 330 | 379 | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 | 776 | 832 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | 24 | 25 |
| Other Liabilities | 96 | 87 | 94 | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | 128 | 150 |
| Total Liabilities | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,037 |
| Fixed Assets | 59 | 65 | 64 | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | 119 | 124 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 | 3 | 0 |
| Investments | 459 | 335 | 381 | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 | 134 | 175 |
| Other Assets | 63 | 46 | 58 | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | 702 | 739 |
| Total Assets | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,037 |
Below is a detailed analysis of the balance sheet data for CARE Ratings Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 30.00 Cr..
- For Reserves, as of Sep 2025, the value is 832.00 Cr.. The value appears strong and on an upward trend. It has increased from 776.00 Cr. (Mar 2025) to 832.00 Cr., marking an increase of 56.00 Cr..
- For Borrowings, as of Sep 2025, the value is 25.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 24.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2025) to 150.00 Cr., marking an increase of 22.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,037.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 958.00 Cr. (Mar 2025) to 1,037.00 Cr., marking an increase of 79.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 124.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Mar 2025) to 124.00 Cr., marking an increase of 5.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 175.00 Cr.. The value appears strong and on an upward trend. It has increased from 134.00 Cr. (Mar 2025) to 175.00 Cr., marking an increase of 41.00 Cr..
- For Other Assets, as of Sep 2025, the value is 739.00 Cr.. The value appears strong and on an upward trend. It has increased from 702.00 Cr. (Mar 2025) to 739.00 Cr., marking an increase of 37.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,037.00 Cr.. The value appears strong and on an upward trend. It has increased from 958.00 Cr. (Mar 2025) to 1,037.00 Cr., marking an increase of 79.00 Cr..
Notably, the Reserves (832.00 Cr.) exceed the Borrowings (25.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 148.00 | 160.00 | 174.00 | 182.00 | 211.00 | 175.00 | 81.00 | 89.00 | 71.00 | 82.00 | 92.00 | 131.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 |
| Working Capital Days | -100 | -82 | -65 | -10 | -1 | 13 | 14 | -3 | 635 | 638 | 591 | 451 |
| ROCE % | 36% | 39% | 46% | 44% | 41% | 35% | 19% | 21% | 16% | 19% | 21% | 25% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 1,476,822 | 0.35 | 236.28 | N/A | N/A | N/A |
| Nippon India Multi Cap Fund | 913,365 | 0.29 | 146.13 | N/A | N/A | N/A |
| SBI Banking & Financial Services Fund | 561,424 | 0.89 | 89.82 | N/A | N/A | N/A |
| Mirae Asset Multicap Fund | 249,778 | 0.87 | 39.96 | N/A | N/A | N/A |
| ICICI Prudential Business Cycle Fund | 203,799 | 0.2 | 32.61 | N/A | N/A | N/A |
| WhiteOak Capital Flexi Cap Fund | 176,786 | 0.4 | 28.28 | N/A | N/A | N/A |
| Mirae Asset Banking and Financial Services Fund | 174,337 | 1.26 | 27.89 | 170,888 | 2026-01-25 07:21:46 | 2.02% |
| ICICI Prudential Smallcap Fund | 146,972 | 0.28 | 23.51 | 59,150 | 2026-01-26 08:54:41 | 148.47% |
| ICICI Prudential Childrens Fund | 109,952 | 1.24 | 17.59 | 108,334 | 2026-01-26 05:56:47 | 1.49% |
| WhiteOak Capital Special Opportunities Fund | 100,035 | 1.14 | 16 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 45.89 | 33.77 | 28.17 | 25.45 | 30.38 |
| Diluted EPS (Rs.) | 45.69 | 33.77 | 28.17 | 25.45 | 30.38 |
| Cash EPS (Rs.) | 50.69 | 37.87 | 32.32 | 28.51 | 33.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 269.37 | 240.23 | 228.63 | 220.20 | 201.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 269.37 | 240.23 | 228.63 | 220.20 | 201.29 |
| Revenue From Operations / Share (Rs.) | 134.41 | 111.11 | 93.94 | 83.53 | 84.33 |
| PBDIT / Share (Rs.) | 68.85 | 53.20 | 46.22 | 36.02 | 43.13 |
| PBIT / Share (Rs.) | 64.94 | 49.69 | 42.67 | 33.42 | 40.48 |
| PBT / Share (Rs.) | 64.23 | 49.12 | 42.34 | 33.27 | 40.27 |
| Net Profit / Share (Rs.) | 46.77 | 34.36 | 28.77 | 25.91 | 30.88 |
| NP After MI And SOA / Share (Rs.) | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 |
| PBDIT Margin (%) | 51.22 | 47.88 | 49.20 | 43.12 | 51.14 |
| PBIT Margin (%) | 48.31 | 44.72 | 45.43 | 40.01 | 48.00 |
| PBT Margin (%) | 47.78 | 44.20 | 45.07 | 39.82 | 47.75 |
| Net Profit Margin (%) | 34.79 | 30.92 | 30.63 | 31.02 | 36.61 |
| NP After MI And SOA Margin (%) | 34.11 | 30.30 | 29.93 | 30.33 | 36.03 |
| Return on Networth / Equity (%) | 17.02 | 14.01 | 12.42 | 11.59 | 15.20 |
| Return on Capital Employeed (%) | 22.60 | 19.43 | 17.80 | 14.65 | 19.27 |
| Return On Assets (%) | 14.32 | 11.94 | 10.83 | 10.32 | 13.32 |
| Asset Turnover Ratio (%) | 0.44 | 0.41 | 0.33 | 0.31 | 0.34 |
| Current Ratio (X) | 7.08 | 8.57 | 10.19 | 11.01 | 10.34 |
| Quick Ratio (X) | 7.08 | 8.57 | 10.19 | 11.01 | 10.34 |
| Dividend Payout Ratio (NP) (%) | 39.20 | 65.09 | 71.02 | 50.99 | 44.79 |
| Dividend Payout Ratio (CP) (%) | 36.11 | 58.94 | 63.07 | 46.24 | 41.19 |
| Earning Retention Ratio (%) | 60.80 | 34.91 | 28.98 | 49.01 | 55.21 |
| Cash Earning Retention Ratio (%) | 63.89 | 41.06 | 36.93 | 53.76 | 58.81 |
| Interest Coverage Ratio (X) | 97.76 | 92.77 | 137.04 | 230.27 | 205.78 |
| Interest Coverage Ratio (Post Tax) (X) | 67.41 | 60.91 | 86.31 | 166.65 | 148.31 |
| Enterprise Value (Cr.) | 3207.01 | 3284.31 | 1859.53 | 1441.35 | 932.75 |
| EV / Net Operating Revenue (X) | 7.97 | 9.90 | 6.67 | 5.82 | 3.75 |
| EV / EBITDA (X) | 15.56 | 20.68 | 13.55 | 13.50 | 7.34 |
| MarketCap / Net Operating Revenue (X) | 8.19 | 10.06 | 6.84 | 6.13 | 4.88 |
| Retention Ratios (%) | 60.79 | 34.90 | 28.97 | 49.00 | 55.20 |
| Price / BV (X) | 4.09 | 4.65 | 2.84 | 2.34 | 2.06 |
| Price / Net Operating Revenue (X) | 8.19 | 10.06 | 6.84 | 6.13 | 4.88 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.04 | 0.07 |
After reviewing the key financial ratios for CARE Ratings Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 45.89. This value is within the healthy range. It has increased from 33.77 (Mar 24) to 45.89, marking an increase of 12.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 45.69. This value is within the healthy range. It has increased from 33.77 (Mar 24) to 45.69, marking an increase of 11.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 50.69. This value is within the healthy range. It has increased from 37.87 (Mar 24) to 50.69, marking an increase of 12.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.37. It has increased from 240.23 (Mar 24) to 269.37, marking an increase of 29.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.37. It has increased from 240.23 (Mar 24) to 269.37, marking an increase of 29.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 134.41. It has increased from 111.11 (Mar 24) to 134.41, marking an increase of 23.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 68.85. This value is within the healthy range. It has increased from 53.20 (Mar 24) to 68.85, marking an increase of 15.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 64.94. This value is within the healthy range. It has increased from 49.69 (Mar 24) to 64.94, marking an increase of 15.25.
- For PBT / Share (Rs.), as of Mar 25, the value is 64.23. This value is within the healthy range. It has increased from 49.12 (Mar 24) to 64.23, marking an increase of 15.11.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 46.77. This value is within the healthy range. It has increased from 34.36 (Mar 24) to 46.77, marking an increase of 12.41.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.85. This value is within the healthy range. It has increased from 33.67 (Mar 24) to 45.85, marking an increase of 12.18.
- For PBDIT Margin (%), as of Mar 25, the value is 51.22. This value is within the healthy range. It has increased from 47.88 (Mar 24) to 51.22, marking an increase of 3.34.
- For PBIT Margin (%), as of Mar 25, the value is 48.31. This value exceeds the healthy maximum of 20. It has increased from 44.72 (Mar 24) to 48.31, marking an increase of 3.59.
- For PBT Margin (%), as of Mar 25, the value is 47.78. This value is within the healthy range. It has increased from 44.20 (Mar 24) to 47.78, marking an increase of 3.58.
- For Net Profit Margin (%), as of Mar 25, the value is 34.79. This value exceeds the healthy maximum of 10. It has increased from 30.92 (Mar 24) to 34.79, marking an increase of 3.87.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.11. This value exceeds the healthy maximum of 20. It has increased from 30.30 (Mar 24) to 34.11, marking an increase of 3.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.02. This value is within the healthy range. It has increased from 14.01 (Mar 24) to 17.02, marking an increase of 3.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.60. This value is within the healthy range. It has increased from 19.43 (Mar 24) to 22.60, marking an increase of 3.17.
- For Return On Assets (%), as of Mar 25, the value is 14.32. This value is within the healthy range. It has increased from 11.94 (Mar 24) to 14.32, marking an increase of 2.38.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.44. It has increased from 0.41 (Mar 24) to 0.44, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 7.08. This value exceeds the healthy maximum of 3. It has decreased from 8.57 (Mar 24) to 7.08, marking a decrease of 1.49.
- For Quick Ratio (X), as of Mar 25, the value is 7.08. This value exceeds the healthy maximum of 2. It has decreased from 8.57 (Mar 24) to 7.08, marking a decrease of 1.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 39.20. This value is within the healthy range. It has decreased from 65.09 (Mar 24) to 39.20, marking a decrease of 25.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 36.11. This value is within the healthy range. It has decreased from 58.94 (Mar 24) to 36.11, marking a decrease of 22.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 60.80. This value is within the healthy range. It has increased from 34.91 (Mar 24) to 60.80, marking an increase of 25.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 63.89. This value is within the healthy range. It has increased from 41.06 (Mar 24) to 63.89, marking an increase of 22.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 97.76. This value is within the healthy range. It has increased from 92.77 (Mar 24) to 97.76, marking an increase of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 67.41. This value is within the healthy range. It has increased from 60.91 (Mar 24) to 67.41, marking an increase of 6.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,207.01. It has decreased from 3,284.31 (Mar 24) to 3,207.01, marking a decrease of 77.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.97. This value exceeds the healthy maximum of 3. It has decreased from 9.90 (Mar 24) to 7.97, marking a decrease of 1.93.
- For EV / EBITDA (X), as of Mar 25, the value is 15.56. This value exceeds the healthy maximum of 15. It has decreased from 20.68 (Mar 24) to 15.56, marking a decrease of 5.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.19. This value exceeds the healthy maximum of 3. It has decreased from 10.06 (Mar 24) to 8.19, marking a decrease of 1.87.
- For Retention Ratios (%), as of Mar 25, the value is 60.79. This value is within the healthy range. It has increased from 34.90 (Mar 24) to 60.79, marking an increase of 25.89.
- For Price / BV (X), as of Mar 25, the value is 4.09. This value exceeds the healthy maximum of 3. It has decreased from 4.65 (Mar 24) to 4.09, marking a decrease of 0.56.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.19. This value exceeds the healthy maximum of 3. It has decreased from 10.06 (Mar 24) to 8.19, marking a decrease of 1.87.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CARE Ratings Ltd:
- Net Profit Margin: 34.79%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.6% (Industry Average ROCE: 23.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.02% (Industry Average ROE: 17.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 67.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 7.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.8 (Industry average Stock P/E: 31.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 34.79%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Rating Services | 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Mumbai Maharashtra 400022 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Najib Shah | Chairman(NonExe.&Ind.Director) |
| Mr. Mehul Harshadray Pandya | Managing Director & Group CEO |
| Mr. Sobhag Mal Jain | Non Exe.Non Ind.Director |
| Mr. V Chandrasekaran | Ind. Non-Executive Director |
| Ms. Sonal Desai | Ind. Non-Executive Director |
| Dr. M Mathisekaran | Ind. Non-Executive Director |
| Mr. Gurumoorthy Mahalingam | Ind. Non-Executive Director |
| Mr. Manoj Chugh | Ind. Non-Executive Director |
| Mr. Rajiv Bansal | Ind. Non-Executive Director |
| Ms. Indrani Banerjee | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of CARE Ratings Ltd?
CARE Ratings Ltd's intrinsic value (as of 29 January 2026) is ₹1486.20 which is 5.22% lower the current market price of ₹1,568.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹4,711 Cr. market cap, FY2025-2026 high/low of ₹1,965/1,052, reserves of ₹832 Cr, and liabilities of ₹1,037 Cr.
What is the Market Cap of CARE Ratings Ltd?
The Market Cap of CARE Ratings Ltd is 4,711 Cr..
What is the current Stock Price of CARE Ratings Ltd as on 29 January 2026?
The current stock price of CARE Ratings Ltd as on 29 January 2026 is ₹1,568.
What is the High / Low of CARE Ratings Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CARE Ratings Ltd stocks is ₹1,965/1,052.
What is the Stock P/E of CARE Ratings Ltd?
The Stock P/E of CARE Ratings Ltd is 30.8.
What is the Book Value of CARE Ratings Ltd?
The Book Value of CARE Ratings Ltd is 288.
What is the Dividend Yield of CARE Ratings Ltd?
The Dividend Yield of CARE Ratings Ltd is 1.15 %.
What is the ROCE of CARE Ratings Ltd?
The ROCE of CARE Ratings Ltd is 24.6 %.
What is the ROE of CARE Ratings Ltd?
The ROE of CARE Ratings Ltd is 18.0 %.
What is the Face Value of CARE Ratings Ltd?
The Face Value of CARE Ratings Ltd is 10.0.